Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine Injection

Brand(s)
Menveo
Category(s)
other
SPL Type(s)
Vaccine
Master SPL
Novartis Vaccines And Diagnostics S.R.L. (2013-08-02)
Oldest Current Product
2010-02-19
License(s)
BLA
RxNORM
INJECTION\NEISSERIA MENINGITIDIS SEROGROUP A OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE:NEISSERIA MENINGITIDIS SEROGROUP C OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE:NEISSERIA MENINGITIDIS SEROGROUP W-135 OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE:NEISSERIA MENINGITIDIS SEROGROUP Y OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE VACCINE

product(s) by strength(s)

0.5 ml neisseria meningitidis serogroup a oligosaccharide diphtheria crm197 protein conjugate vaccine 0.02 mg/ml / neisseria meningitidis serogroup c oligosaccharide diphtheria crm197 protein conjugate vaccine 0.01 mg/ml / neisseria meningitidis serogroup w-135 oligosaccharide diphtheria crm197 protein conjugate vaccine 0.01 mg/ml / neisseria meningitidis serogroup y oligosaccharide diphtheria crm197 protein conjugate vaccine 0.01 mg/ml injection

original product(s)(s)

#idbrandcategorylabelerfirst marketedapplicationspl
1460280208MenveoBLANovartis Vaccines And Diagnostics S.R.L.2010-02-1912530089dde472-1efb-4630-88bc-41cde216fb3a

application(s)

#idtitleapprovedfda division
1125300Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate VaccineMenveo Application2010-02-19CBER

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
189dde472-1efb-4630-88bc-41cde216fb3a (view SPL)These highlights do not include all the information needed to use MENVEO safely and effectively. See full prescribing information for MENVEO. MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine] Solution for intramuscular injectionInitial U.S. Approval: 2010otherVaccineNovartis Vaccines And Diagnostics S.R.L.MANUFACTURE2013-08-0211460280208

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII